Aurora Cannabis Gross Margin 2017-2024 | ACB
Current and historical gross margin for Aurora Cannabis (ACB) over the last 10 years. The current gross profit margin for Aurora Cannabis as of December 31, 2024 is %.
| Aurora Cannabis Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2024-12-31 | $0.23B | $0.16B | 68.24% |
| 2024-09-30 | $0.22B | $0.12B | 54.38% |
| 2024-06-30 | $0.21B | $0.11B | 55.12% |
| 2024-03-31 | $0.20B | $0.10B | 49.50% |
| 2023-12-31 | $0.20B | $0.05B | 24.62% |
| 2023-09-30 | $0.19B | $0.03B | 17.20% |
| 2023-06-30 | $0.18B | $-0.01B | -2.79% |
| 2022-12-31 | $0.17B | $-0.02B | -11.70% |
| 2022-09-30 | $0.17B | $0.01B | 6.90% |
| 2022-03-31 | $0.18B | $-0.05B | -30.00% |
| 2021-12-31 | $0.19B | $-0.03B | -15.63% |
| 2021-09-30 | $0.20B | $-0.01B | -7.18% |
| 2021-03-31 | $0.20B | $-0.01B | -6.90% |
| 2020-12-31 | $0.20B | $0.08B | 37.81% |
| 2020-09-30 | $0.21B | $0.10B | 50.49% |
| 2020-03-31 | $0.20B | $0.12B | 60.78% |
| 2019-12-31 | $0.19B | $0.13B | 67.72% |
| 2019-09-30 | $0.17B | $0.11B | 65.29% |
| 2018-12-31 | $0.08B | $0.04B | 48.05% |
| 2018-09-30 | $0.05B | $0.02B | 40.00% |
| 2017-12-31 | $0.02B | $0.02B | 80.00% |
| 2017-09-30 | $0.01B | $0.01B | 100.00% |
| 2017-03-31 | $0.01B | $0.01B | 100.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.300B | $0.200B |
| Aurora Cannabis Inc is a Canada-based company engaged in the production and distribution of medical cannabis. The Company is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, home cultivation, wholesale and retail distribution. The Company's purpose-built facilities, which integrate technologies across all processes, are defined by automation and customization. The Company has a funded capacity of more than 500,000 kilograms per year, as well as sales and operations in 24 countries across 5 continents. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $235.226B | 28.28 |
| Boston Scientific (BSX) | United States | $157.620B | 39.46 |
| Stryker (SYK) | United States | $148.687B | 31.09 |
| EssilorLuxottica (ESLOY) | France | $134.580B | 0.00 |
| Medtronic (MDT) | Ireland | $110.773B | 16.17 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.060B | 0.00 |
| Haleon (HLN) | United Kingdom | $49.664B | 28.26 |
| ResMed (RMD) | United States | $36.384B | 27.33 |
| GE HealthCare Technologies (GEHC) | United States | $32.899B | 15.62 |
| Agilent Technologies (A) | United States | $32.353B | 21.37 |
| Terumo (TRUMY) | Japan | $27.583B | 35.83 |
| Insulet (PODD) | United States | $23.046B | 90.46 |
| Koninklijke Philips (PHG) | Netherlands | $22.521B | 16.19 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.865B | 12.12 |
| Baxter (BAX) | United States | $16.144B | 12.05 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.881B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.231B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.723B | 23.40 |
| Lantheus Holdings (LNTH) | United States | $5.316B | 13.41 |
| Prestige Consumer Healthcare (PBH) | United States | $4.327B | 19.33 |
| Perrigo (PRGO) | Ireland | $3.770B | 9.55 |
| Haemonetics (HAE) | United States | $3.462B | 15.08 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.321B | 24.49 |
| Envista Holdings (NVST) | United States | $3.012B | 25.03 |
| QuidelOrtho (QDEL) | United States | $2.190B | 15.06 |
| GN Store Nord (GNNDY) | Denmark | $2.097B | 17.37 |
| LeMaitre Vascular (LMAT) | United States | $1.915B | 42.80 |
| AtriCure (ATRC) | United States | $1.686B | 0.00 |
| Neogen (NEOG) | United States | $1.346B | 17.22 |
| Kestra Medical Technologies (KMTS) | United States | $1.280B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.248B | 12.67 |
| Green Thumb Industries (GTBIF) | United States | $1.207B | 27.14 |
| BioLife Solutions (BLFS) | United States | $1.083B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.976B | 12.48 |
| InMode (INMD) | Israel | $0.933B | 9.40 |
| CeriBell (CBLL) | United States | $0.657B | 0.00 |
| Evolus (EOLS) | United States | $0.642B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.611B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.580B | 0.00 |
| Owens & Minor (OMI) | United States | $0.564B | 4.68 |
| Valneva SE (VALN) | France | $0.536B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.503B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.456B | 0.00 |
| Surmodics (SRDX) | United States | $0.424B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.358B | 0.00 |
| SNDL (SNDL) | Canada | $0.349B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.335B | 12.33 |
| Canopy Growth (CGC) | Canada | $0.325B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.300B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.276B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.269B | 22.67 |
| Verano Holdings (VRNOF) | United States | $0.262B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.257B | 0.00 |
| Cerus (CERS) | United States | $0.256B | 0.00 |
| ZimVie (ZIMV) | United States | $0.247B | 11.24 |
| Biote (BTMD) | United States | $0.218B | 6.12 |
| OraSure Technologies (OSUR) | United States | $0.209B | 0.00 |
| Brainsway (BWAY) | Israel | $0.202B | 53.45 |
| Quanterix (QTRX) | United States | $0.194B | 0.00 |
| Omeros (OMER) | United States | $0.193B | 0.00 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| Organigram Global (OGI) | Canada | $0.181B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.176B | 14.34 |
| TriSalus Life Sciences (TLSI) | United States | $0.173B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.131B | 16.18 |
| Exagen (XGN) | United States | $0.127B | 0.00 |
| Jin Medical (ZJYL) | China | $0.124B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.123B | 0.00 |
| Agape ATP (ATPC) | $0.108B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.099B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.092B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Fonar (FONR) | United States | $0.088B | 11.30 |
| Veru (VERU) | United States | $0.075B | 0.00 |
| Zynex (ZYXI) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.073B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.066B | 0.00 |
| Apyx Medical (APYX) | United States | $0.056B | 0.00 |
| United Health Products (UEEC) | United States | $0.056B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.053B | 0.00 |
| ImmuCell (ICCC) | United States | $0.050B | 0.00 |
| United-Guardian (UG) | United States | $0.040B | 13.87 |
| Rockwell Medical (RMTI) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.036B | 0.00 |
| Safety Shot (SHOT) | United States | $0.029B | 0.00 |
| Nephros (NEPH) | United States | $0.024B | 32.93 |
| Allurion Technologies (ALUR) | United States | $0.024B | 0.00 |
| INLIF (INLF) | $0.019B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Acuren (TIC) | United States | $0.000B | 0.00 |